Ask AI
ProCE Banner Activity

A Roadmap for Managing Refractory CMV

Clinical Thought

Managing refractory cytomegalovirus can be complex, but it doesn’t have to be intimidating. Read on to learn what considerations I account for when formulating a treatment plan. 

Released: July 30, 2025

Share

Provided by

Provided by Clinical Care Options, LLC, in collaboration with ProCE and in partnership with the American Kidney Fund

ProCE Banner
ProCE Banner

Supporters

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Merck & Co., Inc., Rahway, NJ, USA

Partners

American Kidney Fund

ProCE Banner

Disclosure

Primary Author

Marcus Pereira, MD, MPH, FAST: consultant/advisor/speaker: Kamada, Synklino.